Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $332.1500 (-0.31%) ($328.9482 - $341.0800) on Fri. Feb. 16, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 30 | Latest Price | $332.1500(-0.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -4.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | Factors Impacting REGN price | REGN will decline at least -1.02% in a week (0% probabilities). UUP(-10%) VIXM(-7%) TLT(-6%) VFMO(-5%) TIP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | 0 () | Intraday Trend | -0.6% | | | |
|
Resistance Level | $351.59 | 5 Day Moving Average | $332.65(-0.15%) | 10 Day Moving Average | $332.72(-0.17%) | 20 Day Moving Average | $351.59(-5.53%) | To recent high | -15.8% | To recent low | 3% | Market Cap | $35.217b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |